Omega-3 Index

What it actually measures

Most nutrient tests measure what is circulating. This one measures what got built in.

The omega-3 index is the combined EPA and DHA content of your red blood cell membranes, reported as a percentage of the total fatty acids in those membranes.

That distinction matters more than it sounds. A plasma fatty acid measurement reflects what you have eaten recently, so a fish dinner two days ago moves it. Red blood cells live around 120 days, and the fatty acids incorporated into their membranes reflect your intake over the preceding months.

So the omega-3 index is a status marker in the way HbA1c is a status marker: slow, stable, and difficult to game before an appointment.

It also measures something functionally meaningful rather than incidental. The fatty acid composition of a cell membrane affects how flexible it is, how signalling proteins sit within it, and which inflammatory mediators the cell can produce.

Which is why this is a better question than how many capsules you take.

What the population data shows, and why the label misleads

A 2026 analysis of NHANES data collected between August 2021 and August 2023, published in Current Developments in Nutrition, gives the first nationally representative picture.

Among 7,213 people aged 6 and over, 54 percent had an undesirable omega-3 index, defined as below 4 percent. The mean was 4.12 percent, and it increased with age.

The categories used are undesirable below 4, intermediate 4 to 8, and optimal above 8. On that framing, more than half the population sits in the worst band and the average person sits barely into the second.

Among adults, the index was higher in females, in non-Hispanic Asian participants, in people above the poverty line, in those with education beyond high school, in nonsmokers, in supplement users, and in people with a healthy weight.

The authors concluded that the US population falls short of the dietary recommendations required to achieve an optimal index.

Now the practical reason to measure rather than assume. A 2018 review in The Annals of Thoracic Surgery noted that commercially available fish oil supplements contain highly variable actual amounts of EPA and DHA.

So the number on the front of a bottle is frequently the total fish oil rather than the active fatty acids, and what you are actually taking is less certain than the label implies. Measuring your membranes sidesteps the whole question.

What moves it

Down: low intake of oily fish, which is the main driver. Supplements with low actual EPA and DHA content relative to their label. Smoking, which is associated with a lower index. High intake of omega-6 relative to omega-3, since they compete for the same enzymes. And simply time, since membrane turnover means the index falls when intake stops.

Up: oily fish, which is by far the most efficient route: salmon, mackerel, sardines, anchovies and herring. EPA and DHA supplements, with attention to the actual EPA and DHA figures rather than the total oil. Algal oil, which is the plant-derived source of EPA and DHA and matters for anyone not eating fish. Plant sources like flax provide ALA, which converts to EPA and DHA inefficiently in humans.

The honest hedge

I am not a doctor and I am not diagnosing anyone.

The categories here, undesirable below 4 and optimal above 8, come from research linking the index to cardiovascular risk, and they are more established than most functional targets on this site. They are still cut points on a continuous measure rather than physiological cliffs.

I would be careful about one leap in particular. Knowing that a low index is associated with higher risk is not the same as knowing that raising yours reduces your risk. Large omega-3 supplementation trials have produced genuinely mixed results, and that is worth acknowledging rather than skipping past.

What the index is unambiguously good for is telling you your actual status rather than your assumed status, which given the label variability is worth something on its own.

One practical caution: if you take an anticoagulant or antiplatelet medication, the omega-3 interaction page covers where that genuinely matters, and it belongs in a conversation with your prescriber.

And the food route beats the capsule route for reasons beyond the fatty acids, since oily fish brings protein, vitamin D3, selenium and iodine along with it.

So. What to actually do.

Tonight, at no cost. Read the back of your fish oil bottle and find the actual EPA and DHA amounts, which are usually well below the headline figure on the front. Most people have never looked.

Count your oily fish. Two to three servings a week of salmon, mackerel, sardines, anchovies or herring is the food route, and it is the most efficient one.

Do not rely on flax to do this job. Plant sources provide ALA, which converts to EPA and DHA inefficiently in humans. If you do not eat fish, algal oil is the direct source.

Measure rather than assume. Given the documented variability in supplement content, testing your membranes answers a question the label cannot.

Give it three to four months before retesting. Red cells live around 120 days, so the index moves on that timescale rather than in weeks.

Buy from a manufacturer that publishes third-party testing. That is worth more than a marginal price difference when the active content varies.

Raise it with your prescriber if you take a blood thinner. That is where the interaction genuinely matters.

You are not what you swallow. You are what got built into the membranes of your cells over the last four months, which is a slower and more honest accounting.

Your body is not broken. It is blocked. And sometimes the block is that the capsule you have taken faithfully for years contains considerably less of the active thing than the front of the bottle suggested.

Go read the back of the label.